Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

12.520
-0.990-7.33%
Volume:12.65M
Turnover:163.83M
Market Cap:22.12B
PE:28.14
High:13.860
Open:13.800
Low:12.510
Close:13.510
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:2.10
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.445
ROE:12.77%
ROA:4.28%
PB:2.46
PE(LYR):28.14
PS:6.80

Loading ...

Movement Alert|InnoCare Pharma Falls 5.04% in Regular Trading, Biotech Sector Sell-Off Compounds Post-Catalyst Profit-Taking

Market Focus
·
Jul 17

InnoCare Pharma's Phase II Study of Vitiligo Drug Shows Consistent Safety, Efficacy

MT Newswires Live
·
Jul 16

Innocare's TYK2 Inhibitor Soficitinib Meets Primary Endpoint in Phase II Vitiligo Study

Stock News
·
Jul 16

Phase III Trial for Innocare's Atopic Dermatitis Drug Meets Primary Endpoint

Stock News
·
Jul 15

Movement Alert|InnoCare Pharma Rises 5.09% in Regular Trading, Biotech Sector Rallies as CDH17 ADC Clinical Data Published

Market Focus
·
Jul 15

InnoCare Pharma (SEHK:9969) Is Up 6.6% After First CDH17 ADC Enters Human Trials

Simply Wall St.
·
Jul 14

Is InnoCare Pharma (SEHK:9969) Undervalued On Its Breakthrough Lupus Trial Results?

Simply Wall St.
·
Jul 11

Movement Alert|InnoCare Pharma Rises 5.07% in Regular Trading, HK Innovative Drug Sector Rallies as ADC Pipeline Advances

Market Focus
·
Jul 10

Innocare Pharma Shares Advance with Robust Quarterly Earnings Growth

Deep News
·
Jul 09

Hong Kong Market Closes Higher, Healthcare and Tech Stocks Lead Gains While AI Hardware Sector Plunges

Stock News
·
Jul 06

Biopharma Stocks Continue to Rally in Early Trading Session

Deep News
·
Jul 06

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Innocare's Stock Surges Over 9% as First Patient Dosed with Novel In-house Developed CDH17-Targeting ADC Drug

Deep News
·
Jul 06

Movement Alert|InnoCare Pharma Rises 6.65% in Regular Trading, Self-Developed ADC Drug ICP-B208 Completes First Patient Dosing

Market Focus
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

Innocare Shares Surge Over 8% Following First Patient Dosing of Novel In-House ADC Drug

Stock News
·
Jul 06

InnoCare issues 1.91 million RSUs under 2023 Share Award Scheme, equal to 0.11% of share capital

Bulletin Express
·
Jun 30

Innocare Pharma Issues 2.42 Million New Shares Under 2024 Equity Incentive Plan

Stock News
·
Jun 26

Extensive Orelabrutinib Data Across Regions Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

Simply Wall St.
·
Jun 22

InnoCare Pharma (SEHK:9969) Stock Could Be 45% Undervalued After EHA 2026 Data

Simply Wall St.
·
Jun 21